.biofargo-table-wrapper {overflow-x: auto;margin: 20px 0;-webkit-overflow-scrolling: touch;}.biofargo-spec-table {width: 100%;border-collapse: collapse;border: 1px solid #dee2e6;min-width: 600px;background: #fff;}.biofargo-spec-table th,.biofargo-spec-table td {border: 1px solid #dee2e6;padding: 12px;vertical-align: middle;white-space: normal;word-break: break-word;}@media (max-width: 600px) {.biofargo-table-wrapper {border: 1px solid #eee;border-radius: 8px;padding: 6px;background: #fff;}.biofargo-spec-table {min-width: 720px;}} Description The nucleoprotein (NP) of human parainfluenza virus type 2 (HPIV2), recombinantly expressed, can be used in immunoassays, antibody screening, or as an antigen control. Specifications Product Details Source HPIV-2 /Greer/AB176531 Japan 2004 Expression Host E. coli Molecular Mass 61.3 kDa Formulation Purified, Liquid Purification >95% Buffer PBS, pH7.4 Storage For long term storage, the product should be stored at -20°C or lower. Validity 3 years Instructions for Use Dissolve the lyophilized powder in an appropriate sterile buffer in a sterile environment before use. Prepare and dilute the solution according to experimental requirements to ensure accurate and reproducible results. Do not mix with other similar products to avoid cross-reactivity and potential interference. Cautions • Research Use Only: This product is not suitable for clinical diagnostics or therapeutic applications. • Preservation: Handle according to instructions to preserve its activity and stability. • Support: Contact our technical support team if you encounter any issues or questions. Documents 📄 Download COA 📄 Download MSDS
